Back

Comparable prognostic impacts of plasma B-type natriuretic peptide levels among patients with heart failure with preserved, mid-range and reduced left ventricular ejection fraction

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Biomarkers Natriuretic peptides HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Mr Shintaro Kasahara

Sendai Medical Center, Sendai (Japan)

25 More presentations in this session

Presentation thumbnail
Association between in-hospital variation of natriuretic peptides and short term outcomes in patients hospitalised for worsening chronic heart failure (data from FERIC-RO)
Doctor I. Cosei (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Unbalanced plasma catestatin and norepinephrine predicted adverse outcomes of chronic heart failure
Doctor S. Chu (Beijing, CN)
Presentation thumbnail
Natriuretic peptides are mainly measured in elderlies, but remain largely underused and sometimes misused: results of big data analysis
Mr M. Lescroart (Paris, FR)
Abstract
Presentation thumbnail
Association between NT-proBNP and metabolic status in young healthy adults.
Doctor A. Akopyan (Moscow, RU)
Abstract
Presentation thumbnail
BNP, Galectine-3and ST-2 cut-off values for long term risk assessment in chronic heart failure patients
Doctor C. Vella (Milan, IT)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Biomarkers

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources